Balance of innovation and safety needed when treating retinoblastoma

KOLOA, Hawaii — Balancing innovation and safety is necessary in the field of retinoblastoma, according to a speaker here.
“It’s always important to remember that we are eye doctors, and these are children with a disease that, if untreated or inappropriately treated, can kill the child,” Jesse L. Berry, MD, said at Retina 2023. “The number one goal is to save the child’s life, and then their eye, then their vision.”
Retinoblastoma is the most common primary intraocular tumor in children, but it is rare, with only approximately 300 cases per year in the